K E Aldridge

1.6k total citations
46 papers, 1.4k citations indexed

About

K E Aldridge is a scholar working on Clinical Biochemistry, Pharmacology and Infectious Diseases. According to data from OpenAlex, K E Aldridge has authored 46 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Clinical Biochemistry, 16 papers in Pharmacology and 13 papers in Infectious Diseases. Recurrent topics in K E Aldridge's work include Bacterial Identification and Susceptibility Testing (21 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers) and Antibiotic Resistance in Bacteria (10 papers). K E Aldridge is often cited by papers focused on Bacterial Identification and Susceptibility Testing (21 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers) and Antibiotic Resistance in Bacteria (10 papers). K E Aldridge collaborates with scholars based in United States, United Kingdom and China. K E Aldridge's co-authors include Charles V. Sanders, Robert L. Marier, S M Finegold, Deborah Ashcraft, J. Paul O'Keefe, Timothy J. Cleary, G J Cuchural, Paul B. Iannini, Francis P. Tally and Gale B. Hill and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

K E Aldridge

46 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K E Aldridge United States 22 582 367 366 333 318 46 1.4k
D. Daneau Belgium 20 344 0.6× 497 1.4× 309 0.8× 442 1.3× 505 1.6× 53 1.6k
I. Braveny Germany 13 483 0.8× 269 0.7× 679 1.9× 332 1.0× 373 1.2× 59 1.4k
Ronald N. Jones United States 18 484 0.8× 415 1.1× 550 1.5× 675 2.0× 454 1.4× 45 1.5k
S K Spangler United States 24 387 0.7× 667 1.8× 443 1.2× 533 1.6× 589 1.9× 49 1.4k
L. A. McDermott United States 21 497 0.9× 236 0.6× 648 1.8× 343 1.0× 410 1.3× 54 1.4k
J. H. Jorgensen United States 18 220 0.4× 258 0.7× 404 1.1× 293 0.9× 432 1.4× 43 1.3k
C. Pierson United States 17 526 0.9× 132 0.4× 557 1.5× 213 0.6× 430 1.4× 25 1.2k
Michael A. Pfaller United States 18 316 0.5× 211 0.6× 471 1.3× 299 0.9× 389 1.2× 27 1.0k
Eugenio A. Debbia Italy 21 251 0.4× 312 0.9× 577 1.6× 541 1.6× 667 2.1× 94 1.6k
P. G. Pitsakis United States 16 457 0.8× 221 0.6× 652 1.8× 234 0.7× 307 1.0× 24 1.1k

Countries citing papers authored by K E Aldridge

Since Specialization
Citations

This map shows the geographic impact of K E Aldridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K E Aldridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K E Aldridge more than expected).

Fields of papers citing papers by K E Aldridge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K E Aldridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K E Aldridge. The network helps show where K E Aldridge may publish in the future.

Co-authorship network of co-authors of K E Aldridge

This figure shows the co-authorship network connecting the top 25 collaborators of K E Aldridge. A scholar is included among the top collaborators of K E Aldridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K E Aldridge. K E Aldridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Vyomesh, K E Aldridge, John F. Ensley, et al.. (2002). Laminin‐γ2 overexpression in head‐and‐neck squamous cell carcinoma. International Journal of Cancer. 99(4). 583–588. 39 indexed citations
2.
Aldridge, K E & William D. Johnson. (1997). A comparison of susceptibility results of the Bacteroides fragilis group and other anaerobes by traditional MIC results and statistical methods. Journal of Antimicrobial Chemotherapy. 39(3). 319–324. 3 indexed citations
3.
Green, Michael H.L., Jillian E. Lowe, Alastair P.W. Waugh, et al.. (1994). Effect of diet and vitamin C on DNA strand breakage in freshly-isolated human white blood cells. Mutation Research/DNAging. 316(2). 91–102. 115 indexed citations
4.
5.
Beare, David, K E Aldridge, Michael R. O’Donovan, & Jane Cole. (1993). An improved procedure for the in vitro expansion of human T-lymphocyte clones for mutant analysis. Mutation Research/Environmental Mutagenesis and Related Subjects. 291(3). 207–212. 8 indexed citations
6.
Sanders, Charles V. & K E Aldridge. (1992). Current antimicrobial therapy of anaerobic infections. European Journal of Clinical Microbiology & Infectious Diseases. 11(11). 999–1011. 14 indexed citations
7.
Barry, A L, Peter Fuchs, E. Gerlach, et al.. (1990). Multilaboratory Evaluation of an Agar Diffusion Disk Susceptibility Test for Rapidly Growing Anaerobic Bacteria. Clinical Infectious Diseases. 12(Supplement_2). S210–S217. 29 indexed citations
8.
Aldridge, K E, et al.. (1990). Discordant results between the broth disk elution and broth microdilution susceptibility tests with Bacteroides fragilis group isolates. Journal of Clinical Microbiology. 28(2). 375–378. 5 indexed citations
9.
Spencer, Charles H., et al.. (1989). Fusobacterium necrophorum Sepsis With Cerebral Infarction. Southern Medical Journal. 82(8). 1040–1043. 9 indexed citations
10.
Barry, A L, K E Aldridge, S D Allen, et al.. (1988). In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101. European Journal of Clinical Microbiology & Infectious Diseases. 7(6). 794–798. 3 indexed citations
11.
Aldridge, K E, et al.. (1987). Comparative in vitro activity of the two new oral cephalosporin metabolites RO 19-5247 and RO 15-8074. European Journal of Clinical Microbiology & Infectious Diseases. 6(5). 564–569. 5 indexed citations
12.
Jones, Ronald N., A L Barry, K E Aldridge, & E. Gerlach. (1987). Comparative antimicrobial activity of aminothiazolyl methoxyimino cephalosporins against anaerobic bacteria, including 100 cefoxitin-resistant isolates. Diagnostic Microbiology and Infectious Disease. 8(3). 157–163. 9 indexed citations
13.
Aldridge, K E, et al.. (1987). Comparative in vitro activity of the new oral cephalosporin BMY-28100. European Journal of Clinical Microbiology & Infectious Diseases. 6(2). 170–172. 13 indexed citations
14.
Aldridge, K E, Charles V. Sanders, & Robert L. Marier. (1984). In vitro synergy and potentiation between cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides.. PubMed. 2(3 Suppl). 47S–53S. 20 indexed citations
15.
Cuchural, G J, Francis P. Tally, N V Jacobus, et al.. (1984). Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982. Antimicrobial Agents and Chemotherapy. 26(2). 145–148. 69 indexed citations
16.
17.
Aldridge, K E & B C Cole. (1978). Immunofluorescence and electron microscopy of the attachment of Mycoplasma synoviae to chicken embryo fibroblasts. Infection and Immunity. 21(1). 328–332. 7 indexed citations
18.
Cole, B C, K E Aldridge, & John Ward. (1977). Mycoplasma-dependent activation of normal lymphocytes: mitogenic potential of mycoplasmas for mouse lymphocytes. Infection and Immunity. 18(2). 393–399. 46 indexed citations
19.
Aldridge, K E, B C Cole, & John Ward. (1977). Mycoplasma-dependent activation of normal lymphocytes: induction of a lymphocyte-mediated cytotoxicity for allogeneic and syngeneic mouse target cells. Infection and Immunity. 18(2). 377–385. 29 indexed citations
20.
Aldridge, K E. (1975). Growth and cytopathology of Mycoplasma synoviae in chicken embryo cell cultures. Infection and Immunity. 12(1). 198–204. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Daneau Breakdown of academic impact, for papers by I. Braveny Breakdown of academic impact, for papers by Ronald N. Jones Breakdown of academic impact, for papers by S K Spangler Breakdown of academic impact, for papers by L. A. McDermott Breakdown of academic impact, for papers by J. H. Jorgensen Breakdown of academic impact, for papers by C. Pierson Breakdown of academic impact, for papers by Michael A. Pfaller Breakdown of academic impact, for papers by Eugenio A. Debbia Breakdown of academic impact, for papers by P. G. Pitsakis
Rankless by CCL
2026